FindTrial
Sign In

Methotrexate with /without topical calcipotriol-which one is better in plaque psoriasis

Efficacy and safety of methotrexate alone and as add on to topical calcipotriol in plaque psoriasis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/013351
Enrollment
50
Registered
2018-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Plaque Psoriasis

Interventions

Control Intervention1: Topical calcipotriol: Topical calcipotriol 0.005% (w/w in ointment base) applied twice daily for total 16 weeks

Sponsors

Department of Pharmacology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age more than 18 years of either gender 2.Treatment naive patients of plaque psoriasis 3.Patients of plaque psoriasis receiving methotrexate

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women 2.Patients immunocompromised due to drug or disease/impaired liver/renal/hematological functions

Design outcomes

Primary

MeasureTime frame
To evaluate and compare the effectiveness and safety of methotrexate alone versus methotrexate with topical calcipotriolTimepoint: Baseline,4 weeks,8 weeks,16 weeks—

Secondary

MeasureTime frame
To assess and compare the quality of life in plaque psoriasis patientsTimepoint: Baseline and 16 weeks—

Countries

India

Contacts

Public ContactDr Avijit Hazra

Institute of Post graduate Medical Education and Research

moumita.bala@gmail.com8337024704

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026